Funds › Rubric Capital Management LP
Rubric Capital Management LP
13F for Q2 2026, filed Aug 14, 2026. 86 positions worth $10.9B.Managers with more than $100 million in US-listed stocks list their holdings each quarter, within 45 days of quarter end. Long positions only: no short sales or cash.
Latest report
Q2 2026
filed Aug 14, 2026
Reported value
$10.9B
+$1.5B (15.5%) vs Q1 2026
Positions
86
81 in Q1 2026
Top 10 share
46.4%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, what are the biggest new, added, trimmed and exited positions of Rubric Capital Management LP in the latest 13F quarter?
Using 13F.ai, how has Rubric Capital Management LP's portfolio concentration changed over the last four quarters?
Using 13F.ai, which of Rubric Capital Management LP's top holdings have also been bought by insiders recently?
Connect your AI · Plans and the 7-day free trial (card required)
Holdings, Q2 2026
Largest first. Common shares only; puts and calls are under All positions.
| # | The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here. | Filing | ||||
|---|---|---|---|---|---|---|
| 1 | TLN Talen Energy Corporation | 3.60M | $1.4B | 12.7% | Unchanged | 13F ↗ |
| 2 | FTAI FTAI Aviation Ltd. | 3.00M | $811.6M | 7.4% | +16.5% | 13F ↗ |
| 3 | VTRS Viatris Inc. | 34.17M | $542.6M | 5.0% | +2.0% | 13F ↗ |
| 4 | Teva Pharmaceutical Industries Ltd ADR | 15.57M | $527.7M | 4.8% | +2.1% | 13F ↗ |
| 5 | GLNG Golar LNG Limited | 9.18M | $457.5M | 4.2% | Unchanged | 13F ↗ |
| 6 | VST Vistra Corp. | 1.79M | $284.7M | 2.6% | +19.7% | 13F ↗ |
| 7 | TAC TransAlta Corporation | 20.23M | $279.8M | 2.6% | +13.8% | 13F ↗ |
| 8 | FLR Fluor Corporation | 5.02M | $262.9M | 2.4% | New | 13F ↗ |
| 9 | KNSA Kiniksa Pharmaceuticals International, plc | 4.00M | $255.8M | 2.3% | +6.7% | 13F ↗ |
| 10 | BGC BGC Group, Inc. | 23.80M | $254.4M | 2.3% | +2.1% | 13F ↗ |
| 11 | ZM Zoom Communications, Inc. | 2.77M | $238.7M | 2.2% | +176% | 13F ↗ |
| 12 | GIL Gildan Activewear, Inc. | 4.50M | $232.2M | 2.1% | +222% | 13F ↗ |
| 13 | ARQT Arcutis Biotherapeutics, Inc. | 8.27M | $216.9M | 2.0% | Unchanged | 13F ↗ |
| 14 | AMZN Amazon.com, Inc. | 900,000 | $214.5M | 2.0% | New | 13F ↗ |
| 15 | ROIV Roivant Sciences Ltd. | 6.00M | $212.3M | 1.9% | +20.0% | 13F ↗ |
| 16 | ZYME Zymeworks Inc. | 7.00M | $183.0M | 1.7% | Unchanged | 13F ↗ |
| 17 | AMCR Amcor plc | 4.16M | $180.4M | 1.7% | +228% | 13F ↗ |
| 18 | CMPR Cimpress plc · Shs Euro | 1.75M | $178.0M | 1.6% | +7.4% | 13F ↗ |
| 19 | AMRX Amneal Pharmaceuticals, Inc. | 10.17M | $176.0M | 1.6% | -7.9% | 13F ↗ |
| 20 | NRIX Nurix Therapeutics, Inc. | 7.23M | $175.3M | 1.6% | +192% | 13F ↗ |
| 21 | MCY Mercury General Corporation | 1.54M | $164.3M | 1.5% | -28.5% | 13F ↗ |
| 22 | PFSI PennyMac Financial Services, Inc. | 1.70M | $148.1M | 1.4% | +3006% | 13F ↗ |
| 23 | IART Integra LifeSciences Holdings Corporation | 7.75M | $139.3M | 1.3% | Unchanged | 13F ↗ |
| 24 | DK Delek US Holdings, Inc. | 2.69M | $136.5M | 1.3% | Unchanged | 13F ↗ |
| 25 | LBTYA Liberty Global Ltd. Class A | 11.75M | $133.6M | 1.2% | Unchanged | 13F ↗ |
| 26 | MGTX MeiraGTx Holdings plc | 9.10M | $122.9M | 1.1% | +30.0% | 13F ↗ |
| 27 | GEO Geo Group Inc (The) REIT | 4.13M | $122.1M | 1.1% | +10.4% | 13F ↗ |
| 28 | LILAK Liberty Latin America Ltd. Class C | 15.65M | $121.9M | 1.1% | -37.2% | 13F ↗ |
| 29 | SDGR Schrodinger, Inc. | 6.40M | $104.0M | 1.0% | +6.7% | 13F ↗ |
| 30 | ECVT Ecovyst Inc. | 8.21M | $102.2M | 0.9% | -10.1% | 13F ↗ |
| 31 | LBTYK Liberty Global Ltd. Class C | 9.26M | $101.9M | 0.9% | Unchanged | 13F ↗ |
| 32 | COMP Compass, Inc. | 8.22M | $101.3M | 0.9% | +119% | 13F ↗ |
| 33 | NWL Newell Brands Inc. | 16.00M | $98.2M | 0.9% | +4.9% | 13F ↗ |
| 34 | EPC Edgewell Personal Care Company | 3.54M | $95.2M | 0.9% | -11.4% | 13F ↗ |
| 35 | CXW CoreCivic, Inc. | 2.85M | $86.5M | 0.8% | +38.3% | 13F ↗ |
| 36 | ARDX Ardelyx, Inc. | 16.20M | $82.6M | 0.8% | +771% | 13F ↗ |
| 37 | ENOV Enovis Corporation | 3.90M | $80.7M | 0.7% | +59.0% | 13F ↗ |
| 38 | ADMA ADMA Biologics Inc | 9.34M | $78.2M | 0.7% | +416% | 13F ↗ |
| 39 | MNKD MannKind Corporation | 18.00M | $76.7M | 0.7% | +397% | 13F ↗ |
| 40 | DRVN Driven Brands Holdings Inc. | 5.30M | $73.9M | 0.7% | +76.7% | 13F ↗ |
| 41 | OPK Opko Health, Inc. | 47.79M | $71.7M | 0.7% | Unchanged | 13F ↗ |
| 42 | AVO Mission Produce, Inc. | 5.98M | $70.5M | 0.6% | +246% | 13F ↗ |
| 43 | ADEA Adeia Inc. | 2.13M | $70.0M | 0.6% | -50.4% | 13F ↗ |
| 44 | RNW ReNew Energy Global plc | 11.00M | $68.8M | 0.6% | Unchanged | 13F ↗ |
| 45 | SSYS Stratasys, Ltd. | 8.00M | $68.5M | 0.6% | Unchanged | 13F ↗ |
| 46 | SPRY ARS Pharmaceuticals, Inc. | 8.54M | $68.4M | 0.6% | +6.8% | 13F ↗ |
| 47 | ANDE The Andersons, Inc. | 999,559 | $68.4M | 0.6% | +16.8% | 13F ↗ |
| 48 | PRMB Primo Brands Corporation · Common Stocks | 2.67M | $65.3M | 0.6% | -4.0% | 13F ↗ |
| 49 | SON Sonoco Products Company | 1.14M | $64.4M | 0.6% | New | 13F ↗ |
| 50 | STUB StubHub Holdings, Inc. | 5.00M | $64.3M | 0.6% | New | 13F ↗ |
Showing the top 50 of 86 positions. Premium lists every position, plus puts and calls.
Changes since Q1 2026
18 new, 33 added to, 12 trimmed, 13 exited, 23 unchanged. By estimated dollars.
New positions (18)
| FLR Fluor Corporation | 5.02M | New | $262.9M |
| AMZN Amazon.com, Inc. | 900,000 | New | $214.5M |
| SON Sonoco Products Company | 1.14M | New | $64.4M |
| STUB StubHub Holdings, Inc. | 5.00M | New | $64.3M |
| GLXY Galaxy Digital Inc. | 2.34M | New | $64.1M |
| ESTA Establishment Labs Holdings Inc. | 688,325 | New | $59.1M |
| ALVO Alvotech | 15.68M | New | $57.8M |
| VGNT Versigent PLC | 855,163 | New | $35.9M |
| TRIP TripAdvisor, Inc. | 2.44M | New | $33.4M |
| BHVN Biohaven Ltd. | 1.72M | New | $25.6M |
Added to (33)
| GIL Gildan Activewear, Inc. | 4.50M | +222% | $160.2M |
| ZM Zoom Communications, Inc. | 2.77M | +176% | $152.3M |
| PFSI PennyMac Financial Services, Inc. | 1.70M | +3006% | $143.3M |
| AMCR Amcor plc | 4.16M | +228% | $125.4M |
| NRIX Nurix Therapeutics, Inc. | 7.23M | +192% | $115.3M |
| FTAI FTAI Aviation Ltd. | 3.00M | +16.5% | $114.7M |
| ARDX Ardelyx, Inc. | 16.20M | +771% | $73.1M |
| ADMA ADMA Biologics Inc | 9.34M | +416% | $63.0M |
| MNKD MannKind Corporation | 18.00M | +397% | $61.3M |
| COMP Compass, Inc. | 8.22M | +119% | $55.1M |
Trimmed (12)
| LILAK Liberty Latin America Ltd. Class C | 15.65M | -37.2% | -$72.3M |
| ADEA Adeia Inc. | 2.13M | -50.4% | -$71.0M |
| MCY Mercury General Corporation | 1.54M | -28.5% | -$65.4M |
| CRI Carter's, Inc. | 86,844 | -91.5% | -$38.4M |
| PRLB Proto Labs, Inc. | 108,692 | -77.7% | -$30.8M |
| TRVI Trevi Therapeutics, Inc. | 2.50M | -32.5% | -$22.5M |
| LILA Liberty Latin America Ltd. Class A | 3.78M | -37.8% | -$18.0M |
| AMRX Amneal Pharmaceuticals, Inc. | 10.17M | -7.9% | -$15.0M |
| EPC Edgewell Personal Care Company | 3.54M | -11.4% | -$12.2M |
| ECVT Ecovyst Inc. | 8.21M | -10.1% | -$11.5M |
Exited (13)
| CEG Constellation Energy Corporation | 715,000 | Exited | -$199.7M |
| AKAM Akamai Technologies, Inc. | 1.30M | Exited | -$149.3M |
| TDS Telephone and Data Systems, Inc. | 1.85M | Exited | -$77.9M |
| PTGX Protagonist Therapeutics, Inc. | 427,998 | Exited | -$45.1M |
| Calavo Growers Inc | 1.42M | Exited | -$36.5M |
| TSAT Telesat Corporation | 843,781 | Exited | -$30.5M |
| BMRN BioMarin Pharmaceutical Inc. | 440,560 | Exited | -$24.9M |
| INDV Supernus, Inc. | 662,515 | Exited | -$20.2M |
| ACHC Acadia Healthcare Company, Inc. | 850,000 | Exited | -$19.9M |
| CPRI Capri Holdings Limited | 675,000 | Exited | -$11.9M |
The 10 largest of each, by estimated dollars: shares changed times the later report's price. Index tracking, splits and mergers move positions too.
All positions
Search, sort and filter every position, with puts and calls on their own tab. Premium plan.
Every position, puts and calls. Part of Premium.
Compare two quarters
Pick any two quarters: what is new, added to, trimmed or exited. Premium plan.
Any two quarters side by side. Part of Premium.
Reported value by quarter
Value and number of positions at the end of each quarter.
Loading…
Largest positions in earlier quarters
Pick a quarter to see what the fund's biggest positions were then.
Loading…
Ten largest positions
By value, Q2 2026.
Filings
Most recent first, up to 80. An amendment can replace a report or add holdings to it. All 13F filings
Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer